CN Stock MarketDetailed Quotes

Hainan Shuangcheng Pharmaceuticals (002693)

Watchlist
  • 10.47
  • -0.23-2.15%
Not Open May 19 15:00 CST
4.34BMarket Cap134.23P/E (TTM)

Hainan Shuangcheng Pharmaceuticals (002693) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
复杂制剂141.1M50.98%
Polypeptide products84.95M30.69%
Entrusted research and development24.04M8.69%
Other products21.26M7.68%
Other business5.41M1.96%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Industry247.31M89.36%
Service industry29.45M10.64%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Foreign region187.85M67.88%
East China region31.85M11.51%
Central China20.46M7.39%
Southwest area19.18M6.93%
South China9.54M3.45%
North China3.22M1.16%
Northeast area2.62M0.94%
Northwest region2.04M0.74%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19 Eastern Time, Trump warned that Iran might only have a negotiating window until Sunday or early next week, adding that 'it may be Show More